Corporate Partnership Programme
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
EMBL boasts some of the best scientific talent in Europe. Get in touch.
The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.
EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.
Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.
As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.
Industry news from EMBL’s six sites
Alumnus Norbert Kraut reflects on how his time at EMBL led to his successes in addressing hard-to-treat lung cancer.
Edit
EMBL alumnus and Lennart Philipson Awardee Florent Cipriani reflects on his 30 years at EMBL Grenoble and his multidisciplinary career building technologies that enable new discoveries.
Edit
EMBL-EBI receives UKRI Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) funding for enhancing and translating mental-health omics data into the Open Targets Pl…
EditZur Verstärkung unseres HR-/Payroll-Teams am EMBL Heidelberg suchen wir eine engagierte Persönlichkeit mit fundierter Expertise im deutschen Sozialversicherungsrecht. In dieser verantwortungsvollen Rolle sind Sie zentrale Ansprechperson für alle sozialversicherungsrechtlichen Fragestellungen und tra...
Closes on 23rd March. Posted 19th February 2026
EditAre you an experienced career development, learning management, or talent development professional looking to shape strategy at organisational level?EMBL is seeking a strategic and operational expert in professional development who understands how to design scalable learning approaches, embed career...
Closes on 8th March. Posted 19th February 2026
EditYour role Covering a period of absence, we have a new opportunity for a Talent Acquisition Administrator to join our close-knit team for a period of 6 months.As a Talent Acquisition Administrator you'll play a key role in delivering a seamless experience for both our Hiring Managers and our candidat...
Closes on 1st March. Posted 19th February 2026
EditWith support from more than 30 countries, laboratories at six sites across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory (EMBL) is a powerhouse of biological expertise. EMBL is an intergovernmental organisation, headquartered in Heidelberg, and was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.
EMBL currently employs more than 1800 people in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton (near Cambridge), and Rome.
Publishing hundreds of research articles and hosting dozens of conferences every year, EMBL is driving visionary fundamental research and training Europe’s future scientific talent.